{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,14]],"date-time":"2026-01-14T16:03:34Z","timestamp":1768406614406,"version":"3.49.0"},"reference-count":21,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2016,4,1]],"date-time":"2016-04-01T00:00:00Z","timestamp":1459468800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2016,4,1]],"date-time":"2016-04-01T00:00:00Z","timestamp":1459468800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2015,12,7]],"date-time":"2015-12-07T00:00:00Z","timestamp":1449446400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"name":"Diadexus Inc"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinical Biochemistry"],"published-print":{"date-parts":[[2016,4]]},"DOI":"10.1016\/j.clinbiochem.2015.11.018","type":"journal-article","created":{"date-parts":[[2015,12,2]],"date-time":"2015-12-02T07:31:42Z","timestamp":1449041502000},"page":"480-485","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":8,"title":["Evaluation of recombinant enzyme calibration to harmonize lipoprotein-associated phospholipase A2 activity results between instruments"],"prefix":"10.1016","volume":"49","author":[{"given":"Mary Jane","family":"Cerelli","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Karen","family":"Grimm","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiaozhu","family":"Duan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Edie","family":"Mulberg","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maria","family":"Jalilie","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Phillip","family":"Sekella","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marta","family":"Payes","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Heather","family":"Cox","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kenneth E.","family":"Blick","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kenneth C.","family":"Fang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Emi","family":"Zychlinsky","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"11","key":"10.1016\/j.clinbiochem.2015.11.018_bb0005","doi-asserted-by":"crossref","first-page":"2523","DOI":"10.1161\/01.ATV.0000244681.72738.bc","article-title":"Lipoprotein-associated phospholipase A2 protein expression in the natural progression of human coronary atherosclerosis","volume":"26","author":"Kolodgie","year":"2006","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"issue":"5","key":"10.1016\/j.clinbiochem.2015.11.018_bb0010","doi-asserted-by":"crossref","first-page":"923","DOI":"10.1161\/01.ATV.0000160551.21962.a7","article-title":"Role of lipoprotein-associated phospholipase A2 in atherosclerosis: biology, epidemiology, and possible therapeutic target","volume":"25","author":"Zalewski","year":"2005","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"issue":"40","key":"10.1016\/j.clinbiochem.2015.11.018_bb0015","doi-asserted-by":"crossref","first-page":"6256","DOI":"10.2174\/1381612820666140622200916","article-title":"Pathophysiological role and clinical significance of lipoprotein-associated phospholipase A2 (Lp-PLA2) bound to LDL and HDL","volume":"20","author":"Tellis","year":"2014","journal-title":"Curr. Pharm. Des."},{"issue":"Pt 2","key":"10.1016\/j.clinbiochem.2015.11.018_bb0020","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1042\/bj3380479","article-title":"Lipoprotein-associated phospholipase A2, platelet-activating factor acetylhydrolase, generates two bioactive products during the oxidation of low-density lipoprotein: use of a novel inhibitor","volume":"338","author":"MacPhee","year":"1999","journal-title":"Biochem. J."},{"issue":"2","key":"10.1016\/j.clinbiochem.2015.11.018_bb0025","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1007\/s40119-013-0022-3","article-title":"Lp-PLA2 inhibitors for the reduction of cardiovascular events","volume":"2","author":"Steen","year":"2013","journal-title":"Cardiol. Ther."},{"issue":"9725","key":"10.1016\/j.clinbiochem.2015.11.018_bb0030","doi-asserted-by":"crossref","first-page":"1536","DOI":"10.1016\/S0140-6736(10)60319-4","article-title":"Lipoprotein-associated phospholipase A(2) and risk of coronary disease, stroke, and mortality: collaborative analysis of 32 prospective studies","volume":"375","author":"Thompson","year":"2010","journal-title":"Lancet"},{"issue":"3","key":"10.1016\/j.clinbiochem.2015.11.018_bb0035","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1515\/CCLM.2010.075","article-title":"Standardization in clinical enzymology: a challenge for the theory of metrological traceability","volume":"48","author":"Infusino","year":"2010","journal-title":"Clin. Chem. Lab. Med."},{"issue":"2","key":"10.1016\/j.clinbiochem.2015.11.018_bb0040","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1016\/j.atherosclerosis.2008.07.035","article-title":"Plasma lipoprotein-associated phospholipase A2 levels in heart failure: association with mortality in the community","volume":"203","author":"Gerber","year":"2009","journal-title":"Atherosclerosis"},{"issue":"3","key":"10.1016\/j.clinbiochem.2015.11.018_bb0045","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1089\/dia.2010.0175","article-title":"Lipoprotein-associated phospholipase A(2) activity predicts progression of subclinical coronary atherosclerosis","volume":"13","author":"Kinney","year":"2011","journal-title":"Diabetes Technol. Ther."},{"issue":"20","key":"10.1016\/j.clinbiochem.2015.11.018_bb0050","doi-asserted-by":"crossref","first-page":"2053","DOI":"10.1016\/j.jacc.2012.06.057","article-title":"Lipoprotein-associated phospholipase A(2) bound on high-density lipoprotein is associated with lower risk for cardiac death in stable coronary artery disease patients: a 3-year follow-up","volume":"60","author":"Rallidis","year":"2012","journal-title":"J. Am. Coll. Cardiol."},{"issue":"5","key":"10.1016\/j.clinbiochem.2015.11.018_bb0055","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.113.000360","article-title":"Changes in lipoprotein-associated phospholipase A2 activity predict coronary events and partly account for the treatment effect of pravastatin: results from the Long-Term Intervention with Pravastatin in Ischemic Disease study","volume":"2","author":"White","year":"2013","journal-title":"J. Am. Heart Assoc."},{"issue":"5","key":"10.1016\/j.clinbiochem.2015.11.018_bb0060","doi-asserted-by":"crossref","first-page":"932","DOI":"10.1373\/clinchem.2008.103358","article-title":"Variability of lipoprotein-associated phospholipase A2 measurements","volume":"54","author":"McConnell","year":"2008","journal-title":"Clin. Chem."},{"key":"10.1016\/j.clinbiochem.2015.11.018_bb0065","series-title":"Evaluation of Detection Capability for Clinical Laboratory Measurement Procedures; Approved Guideline","author":"CLSI","year":"2012"},{"issue":"5","key":"10.1016\/j.clinbiochem.2015.11.018_bb0070","doi-asserted-by":"crossref","first-page":"877","DOI":"10.1373\/clinchem.2011.180281","article-title":"Relationship of lipoprotein-associated phospholipase A(2) mass and activity with incident vascular events among primary prevention patients allocated to placebo or to statin therapy: an analysis from the JUPITER trial","volume":"58","author":"Ridker","year":"2012","journal-title":"Clin. Chem."},{"key":"10.1016\/j.clinbiochem.2015.11.018_bb0075","series-title":"Evaluation of Linearity of Quantitative Measurement Procedures: A Statistical Approach; Approved Guidance","author":"CLSI","year":"2003"},{"issue":"1","key":"10.1016\/j.clinbiochem.2015.11.018_bb0080","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1093\/clinchem\/46.1.100","article-title":"General Deming regression for estimating systematic bias and its confidence interval in method-comparison studies","volume":"46","author":"Martin","year":"2000","journal-title":"Clin. Chem."},{"key":"10.1016\/j.clinbiochem.2015.11.018_bb0085","series-title":"Evaluation of Precision of Quantitative Measurement Procedures; Approved Guideline","volume":"3","author":"CLSI","year":"2014"},{"issue":"10","key":"10.1016\/j.clinbiochem.2015.11.018_bb0090","first-page":"A266","article-title":"Performance evaluation of an automated assay for lipoprotein-associated phospholipase A2 ((Lp-PLA2) activity","volume":"59","author":"Callanan","year":"2013","journal-title":"Clin. Chem."},{"issue":"14\u201315","key":"10.1016\/j.clinbiochem.2015.11.018_bb0095","doi-asserted-by":"crossref","first-page":"1247","DOI":"10.1016\/j.clinbiochem.2011.07.005","article-title":"Assessment of clinical performance without adequate analytical validation: a prescription for confusion","volume":"44","author":"Oliver","year":"2011","journal-title":"Clin. Biochem."},{"key":"10.1016\/j.clinbiochem.2015.11.018_bb0100","series-title":"Mathematics for the Clinical Laboratory","author":"Doucette","year":"2015"},{"issue":"6","key":"10.1016\/j.clinbiochem.2015.11.018_bb0105","doi-asserted-by":"crossref","first-page":"724","DOI":"10.1093\/clinchem\/26.6.724","article-title":"High-purity 4-nitrophenol: purification, characterization, and specifications for use as a spectrophotometric reference material","volume":"26","author":"Bowers","year":"1980","journal-title":"Clin. Chem."}],"container-title":["Clinical Biochemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0009912015005494?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0009912015005494?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,14]],"date-time":"2025-09-14T15:48:43Z","timestamp":1757864923000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0009912015005494"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,4]]},"references-count":21,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2016,4]]}},"alternative-id":["S0009912015005494"],"URL":"https:\/\/doi.org\/10.1016\/j.clinbiochem.2015.11.018","relation":{},"ISSN":["0009-9120"],"issn-type":[{"value":"0009-9120","type":"print"}],"subject":[],"published":{"date-parts":[[2016,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Evaluation of recombinant enzyme calibration to harmonize lipoprotein-associated phospholipase A2 activity results between instruments","name":"articletitle","label":"Article Title"},{"value":"Clinical Biochemistry","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.clinbiochem.2015.11.018","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2015 The Authors. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}